Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
BRAINSTORM CELL THERAPEUTICS INC. has filed 949 SEC EDGAR filings since 24 May 2001

SEC filing history

Showing 26-50 of 725 matching filings.

Per page
25
Current page
2
25-NSE File 001-36641

25-NSE filing

Filing date
09 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-288322

RW

Filing date
22 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-288520

FORM S-8

Filing date
03 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-288322

FORM S-3

Filing date
25 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36641

ARS

Filing date
16 May 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36641

DEFA14A

Filing date
16 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36641

DEF 14A

Filing date
16 May 2025
Reporting date
25 Jun 2025
Next action
Verify source filing
SCHEDULE 13G File 005-79890

SCHEDULE 13G filing

Filing date
15 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36641

PRE 14A

Filing date
06 May 2025
Reporting date
06 May 2025
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .